Experts have criticised pharmaceutical firm Gilead Sciences after it released data suggesting that its antiviral drug remdesivir can reduce death rates for patients with covid-19. They say the research is intrinsically flawed and that the claimed benefits are overhyped and inappropriately promoted in press releases. The California based company said intravenous remdesivir reduced mortality by…
Archive Online archive 2023 07 October 2023(vol 383, issue 8401) 07 October 2023(vol 383, issue 8401) …
Dear Editor, As a Physician Associate, it has been difficult to read some of the backlash precipitated by the tragic and avoidable death that was…
Casey Quinlan (b 1952), the patient activist known as “Mighty Casey,” died in hospice on 25 April 2023, from a recurrence of metastatic breast cancer.…
### What you need to know Sepsis is a common cause for hospital admission that carries a high risk of death.1 In 2021-22, over 100 000…
Ellen Idler and colleagues argue that durable partnerships with religious bodies can contribute to better population health outcomes The relationship between religion and public health…
Healthcare professionals in Iran are risking their lives to treat the wounded and maintain medical ethics, the global health community must back them Medical impartiality…
Consultant oncologist Alison Birtle talks to Helen Jones about her love of performing and how it is helping her recovery from serious complications of covid…
Myrian describes how an acquired brain injury has affected her, and the challenges she now faces when engaging in healthcare consultations In 2015 I experienced…
Decisions taken to end the universal wearing of face masks in hospitals and doctors’ surgeries are placing patients and staff at greater risk of covid…
Consultant oncologist Alison Birtle talks to Helen Jones about her love of performing and how it is helping her recovery from serious complications of covid…
